A computational method for prioritizing targeted therapies in precision oncology: performance analysis in the SHIVA01 trial.

Petak, Istvan; Kamal, Maud; Dirner, Anna; Bieche, Ivan; Doczi, Robert; Mariani, Odette; Filotas, Peter; Salomon, Anne; Vodicska, Barbara; Servois, Vincent; Varkondi, Edit; Gentien, David; Tihanyi, Dora; Tresca, Patricia; Lakatos, Dora; Servant, Nicolas; Deri, Julia; du Rusquec, Pauline; Hegedus, Csilla; Bello Roufai, Diana; Schwab, Richard; Dupain, Celia; Valyi-Nagy, Istvan T; Le Tourneau, Christophe

Petak, Istvan; Kamal, Maud; Dirner, Anna; Bieche, Ivan; Doczi, Robert; Mariani, Odette; Filotas, Peter; Salomon, Anne; Vodicska, Barbara; Servois, Vincent; Varkondi, Edit; Gentien, David; Tihanyi, Dora; Tresca, Patricia; Lakatos, Dora; Servant, Nicolas; Deri, Julia; du Rusquec, Pauline; Hegedus, Csilla; Bello Roufai, Diana; Schwab, Richard; Dupain, Celia; Valyi-Nagy, Istvan T; Le Tourneau, Christophe.

Afiliação

Petak I; Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary. istvan.petak.dr@gmail.com.
Kamal M; Department of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago, USA. istvan.petak.dr@gmail.com.
Dirner A; Oncompass Medicine, Budapest, Hungary. istvan.petak.dr@gmail.com.
Bieche I; Department of Drug Development and Innovation (D3i), Institute Curie, Paris & Saint-Cloud, France.
Doczi R; Oncompass Medicine, Budapest, Hungary.
Mariani O; Pharmacogenomics unit, Institut Curie, Paris, France.
Filotas P; Oncompass Medicine, Budapest, Hungary.
Salomon A; Department of Biopathology, Institut Curie, Paris, France.
Vodicska B; Oncompass Medicine, Budapest, Hungary.
Servois V; Department of Biopathology, Institut Curie, Paris, France.
Varkondi E; Oncompass Medicine, Budapest, Hungary.
Gentien D; Department of Radiology, Institut Curie, Paris, France.
Tihanyi D; Oncompass Medicine, Budapest, Hungary.
Tresca P; Translational Research Department, Institut Curie, Paris, France.
Lakatos D; Oncompass Medicine, Budapest, Hungary.
Servant N; Department of Drug Development and Innovation (D3i), Institute Curie, Paris & Saint-Cloud, France.
Deri J; Oncompass Medicine, Budapest, Hungary.
du Rusquec P; INSERM U900 Research Unit, Paris & Saint-Cloud, France.
Hegedus C; Oncompass Medicine, Budapest, Hungary.
Bello Roufai D; Department of Drug Development and Innovation (D3i), Institute Curie, Paris & Saint-Cloud, France.
Schwab R; Oncompass Medicine, Budapest, Hungary.
Dupain C; Department of Drug Development and Innovation (D3i), Institute Curie, Paris & Saint-Cloud, France.
Valyi-Nagy IT; Oncompass Medicine, Budapest, Hungary.
Le Tourneau C; Department of Drug Development and Innovation (D3i), Institute Curie, Paris & Saint-Cloud, France.

NPJ Precis Oncol ; 5(1): 59, 2021 Jun 23.

Article em En | MEDLINE | ID: mdl-34162980

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: NPJ Precis Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Hungria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google